A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the commonly administered chemotherapeutic
agents including cisplatin, carboplatin, oxaliplatin, docetaxel and gemcitabine for solid
tumors in clinical oncology, either a single format or given as combinations followed by
surgery are effective in the treatment of relapsed and refractory non-small cell lung cancer
patients.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Collaborators:
Jiangxi Provincial Cancer Hospital Jilin University Shanghai 10th People's Hospital Shanghai Tongji Hospital, Tongji University School of Medicine